Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 165

    1.

    Reduced IGFBP-1 is associated with thickening of the carotid wall in type 2 diabetes.

    Leinonen ES, Salonen JT, Salonen RM, Koistinen RA, Leinonen PJ, Sarna SS, Taskinen MR.

    Diabetes Care. 2002 Oct;25(10):1807-12.PMID: 12351482 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Low circulating levels of insulin-like growth factor binding protein-1 (IGFBP-1) are closely associated with the presence of macrovascular disease and hypertension in type 2 diabetes.

    Heald AH, Siddals KW, Fraser W, Taylor W, Kaushal K, Morris J, Young RJ, White A, Gibson JM.

    Diabetes. 2002 Aug;51(8):2629-36.PMID: 12145180 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Elevated plasma phospholipid transfer protein activity is a determinant of carotid intima-media thickness in type 2 diabetes mellitus.

    de Vries R, Dallinga-Thie GM, Smit AJ, Wolffenbuttel BH, van Tol A, Dullaart RP.

    Diabetologia. 2006 Feb;49(2):398-404. Epub 2005 Dec 23.PMID: 16374627 [PubMed - indexed for MEDLINE]Related articles

    4.

    Circulating insulin-like growth factor-I levels are correlated with the atherosclerotic profile in healthy subjects independently of age.

    Colao A, Spiezia S, Di Somma C, Pivonello R, Marzullo P, Rota F, Musella T, Auriemma RS, De Martino MC, Lombardi G.

    J Endocrinol Invest. 2005 May;28(5):440-8.PMID: 16075928 [PubMed - indexed for MEDLINE]Related articles

    6.

    Relationship between non-enzymatic glycosylation and changes in serum insulin-like growth factor-1 (IGF-1) and IGF-binding protein-3 levels in patients with type 2 diabetes mellitus.

    Cortizo AM, Lee PD, Cédola NV, Jasper H, Gagliardino JJ.

    Acta Diabetol. 1998 Jul;35(2):85-90.PMID: 9747960 [PubMed - indexed for MEDLINE]Related articles

    7.

    The level of 2-h post-challenge glucose is an independent risk factor of carotid intima-media thickness progression in Korean type 2 diabetic patients.

    Kim HJ, Ahn CW, Kang ES, Myoung SM, Cha BS, Won YJ, Lim SK, Kim KR, Huh KB, Lee HC.

    J Diabetes Complications. 2007 Jan-Feb;21(1):7-12.PMID: 17189868 [PubMed - indexed for MEDLINE]Related articles

    8.

    Serum total IGF-I, free IGF-I, and IGFB-1 levels in an elderly population: relation to cardiovascular risk factors and disease.

    Janssen JA, Stolk RP, Pols HA, Grobbee DE, Lamberts SW.

    Arterioscler Thromb Vasc Biol. 1998 Feb;18(2):277-82. Erratum in: Arterioscler Thromb Vasc Biol 1998 Jul;18(7):1197. PMID: 9484994 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Ultrasonographically assessed carotid atherosclerosis in Japanese type 2 diabetic patients: Role of nonesterified fatty acids.

    Taniguchi A, Nakai Y, Fukushima M, Teramura S, Hayashi R, Hama K, Marumoto K, Watanabe T, Yoshioka I, Sakaguchi K, Kishimoto H, Matsushita K, Okumura T, Tokuyama K, Nagasaka S, Sakai M.

    Metabolism. 2002 May;51(5):539-43.PMID: 11979382 [PubMed - indexed for MEDLINE]Related articles

    10.

    Postprandial hypertriglyceridemia and carotid intima-media thickness in north Indian type 2 diabetic subjects.

    Ahmad J, Hameed B, Das G, Siddiqui MA, Ahmad I.

    Diabetes Res Clin Pract. 2005 Aug;69(2):142-50.PMID: 15955588 [PubMed - indexed for MEDLINE]Related articles

    11.

    Advanced glycosylation end products (AGEs), insulin-like growth factor-1 (IGF-1) and IGF-binding protein-3 (IGFBP-3) in patients with type 2 diabetes mellitus.

    Garay-Sevilla ME, Nava LE, Malacara JM, Wróbel K, Wróbel K, Pérez U.

    Diabetes Metab Res Rev. 2000 Mar-Apr;16(2):106-13.PMID: 10751750 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Insulin-like growth factor binding protein-1 in NIDDM: relationship with the insulin resistance syndrome.

    Mohamed-Ali V, Pinkney JH, Panahloo A, Cwyfan-Hughes S, Holly JM, Yudkin JS.

    Clin Endocrinol (Oxf). 1999 Feb;50(2):221-8.PMID: 10396366 [PubMed - indexed for MEDLINE]Related articles

    13.

    Circulating insulin-like growth factor-1 and insulin-like growth factor binding protein-3 are associated with early carotid atherosclerosis.

    Kawachi S, Takeda N, Sasaki A, Kokubo Y, Takami K, Sarui H, Hayashi M, Yamakita N, Yasuda K.

    Arterioscler Thromb Vasc Biol. 2005 Mar;25(3):617-21. Epub 2004 Dec 29.PMID: 15625284 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Carotid artery intima-media complex thickening in patients with relatively long-surviving type 1 diabetes mellitus.

    Distiller LA, Joffe BI, Melville V, Welman T, Distiller GB.

    J Diabetes Complications. 2006 Sep-Oct;20(5):280-4.PMID: 16949514 [PubMed - indexed for MEDLINE]Related articles

    15.

    Insulin-like growth factor binding protein-2 (IGFBP-2) is a marker for the metabolic syndrome.

    Heald AH, Kaushal K, Siddals KW, Rudenski AS, Anderson SG, Gibson JM.

    Exp Clin Endocrinol Diabetes. 2006 Jul;114(7):371-6.PMID: 16915540 [PubMed - indexed for MEDLINE]Related articles

    16.

    Insulin resistance, cardiovascular risk factors and ultrasonically measured early arterial disease in normotensive Type 2 diabetic subjects.

    Kong C, Elatrozy T, Anyaoku V, Robinson S, Richmond W, Elkeles RS.

    Diabetes Metab Res Rev. 2000 Nov-Dec;16(6):448-53.PMID: 11114104 [PubMed - indexed for MEDLINE]Related articles

    17.

    Insulin-like growth factor-1 and its binding proteins, IGFBP-1 and IGFBP-3, in adolescents with type-1 diabetes mellitus and microalbuminuria.

    Wedrychowicz A, Dziatkowiak H, Nazim J, Sztefko K.

    Horm Res. 2005;63(5):245-51. Epub 2005 May 24.PMID: 15920342 [PubMed - indexed for MEDLINE]Related articles

    18.

    Increased levels of insulin-like growth factor binding protein-3 in hypertensive patients with carotid atherosclerosis.

    Watanabe T, Itokawa M, Nakagawa Y, Iguchi T, Katagiri T.

    Am J Hypertens. 2003 Sep;16(9 Pt 1):754-60.PMID: 12944034 [PubMed - indexed for MEDLINE]Related articles

    19.

    Relative fasting hypoinsulinaemia and ultrasonically measured early arterial disease in type 2 diabetes. The SENDCAP Study Group, St. Mary's, Ealing, Northwick Park Diabetes Cardiovascular Disease Prevention Study.

    Elkeles RS, Diamond JR, El-Bahghouti N, Dhanjil S, Nicolaides A, Geroulakos G, Renton S, Anyaoku V, Richmond W, Mather H, Sharp P.

    Diabet Med. 1996 Mar;13(3):247-53.PMID: 8689846 [PubMed - indexed for MEDLINE]Related articles

    20.

    [IGFBP-1 and its protective role in the pathogenesis of microangiopathy in type 1 diabetes mellitus]

    Krsek M, Prázný M, Skrha J, Justová V, Lacinová Z.

    Cas Lek Cesk. 2001 Apr 26;140(8):234-7. Czech. PMID: 11392040 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data